Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma.

• Determining vaccine dose-level protection is essential to minimize program costs and increase mass vaccination program feasibility. Currently, a 3-dose vaccination schedule is recommended for both the quadrivalent and bivalent human papillomavirus (HPV) vaccines. Although the primary goal of HPV vaccination programs is to prevent cervical cancer, condyloma related to HPV types 6 and 11 is also prevented with the quadrivalent vaccine and represents the earliest measurable preventable disease outcome for the HPV vaccine.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Hälsovetenskap -- Arbetsmedicin och miljömedicin (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Health Sciences -- Occupational Health and Environmental Health (hsv//eng)

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Dermatologi och venereologi (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Dermatology and Venereal Diseases (hsv//eng)

Nyckelord

Condylomata Acuminata: epidemiology

Condylomata Acuminata: prevention & control

Papillomavirus Infections: prevention & control

Papillomavirus Vaccines: administration & dosage

Registries: statistics & numerical data

Sweden: epidemiology

Uterine Cervical Neoplasms: prevention & control

Vaccination: statistics & numerical data

Publikations- och innehållstyp

art (ämneskategori)

ref (ämneskategori)